Relpax is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Roerig. The primary component is Eletriptan Hydrobromide.
| Product ID | 0049-2330_4fe86f16-7d84-4192-bfcb-f600ef55e29e |
| NDC | 0049-2330 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Relpax |
| Generic Name | Eletriptan Hydrobromide |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2002-12-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021016 |
| Labeler Name | Roerig |
| Substance Name | ELETRIPTAN HYDROBROMIDE |
| Active Ingredient Strength | 20 mg/1 |
| Pharm Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2002-12-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021016 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-02-17 |
| Marketing Category | NDA |
| Application Number | NDA021016 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2002-12-26 |
| Ingredient | Strength |
|---|---|
| ELETRIPTAN HYDROBROMIDE | 20 mg/1 |
| SPL SET ID: | 85745375-fcb6-4edc-b6db-a77b4a5f3e8c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0049-2330 | Relpax | eletriptan hydrobromide |
| 0049-2340 | Relpax | eletriptan hydrobromide |
| 21695-871 | Relpax | eletriptan hydrobromide |
| 63539-234 | Relpax | Relpax |
| 0093-8310 | Eletriptan Hydrobromide | Eletriptan Hydrobromide |
| 0093-8311 | Eletriptan Hydrobromide | Eletriptan Hydrobromide |
| 0378-4287 | Eletriptan Hydrobromide | eletriptan hydrobromide |
| 0378-4288 | Eletriptan Hydrobromide | eletriptan hydrobromide |
| 27241-039 | eletriptan hydrobromide | eletriptan hydrobromide |
| 27241-040 | eletriptan hydrobromide | eletriptan hydrobromide |
| 55700-756 | eletriptan hydrobromide | eletriptan hydrobromide |
| 59651-104 | Eletriptan Hydrobromide | Eletriptan Hydrobromide |
| 59651-105 | Eletriptan Hydrobromide | Eletriptan Hydrobromide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RELPAX 75655002 2747535 Dead/Cancelled |
Pfizer Inc. 1999-03-05 |
![]() RELPAX 75249087 2487796 Live/Registered |
Pfizer Inc. 1997-02-27 |